Robert E. Rangno
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy 3
- Analytical Chemistry top 2%
- Analytical Methods in Pharmaceuticals 3
-
- Anesthesia and Sedative Agents 5
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy 3
-
- Cardiac electrophysiology and arrhythmias 4
-
- Cardiovascular Syncope and Autonomic Disorders 3
- Lipoproteins and Cardiovascular Health 3
-
- Health Systems, Economic Evaluations, Quality of Life 3
-
- Analytical Chemistry and Chromatography 2
Robert E. Rangno
27 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 97
- Pharmacology 227
- Analytical Chemistry 166
- Anesthesiology and Pain Medicine 82
- Pharmacology 223
- Cardiology and Cardiovascular Medicine 256
Countries citing papers authored by Robert E. Rangno
This map shows the geographic impact of Robert E. Rangno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Rangno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Rangno more than expected).
Fields of papers citing papers by Robert E. Rangno
This network shows the impact of papers produced by Robert E. Rangno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Rangno. The network helps show where Robert E. Rangno may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert E. Rangno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 2 | |
| 2 | Primary prevention of heart disease and stroke: a simplified approach to estimating risk of events and making drug treatment decisions. | 1997 | 22 |
| 3 | 1986 | 81 | |
| 4 | 1982 | 37 | |
| 5 | 1982 | 15 | |
| 6 | 1982 | 6 | |
| 7 | 1982 | 27 | |
| 8 | 1982 | 11 | |
| 9 | Stopping beta blockers in patients with angina. | 1981 | 2 |
| 10 | 1979 | 148 | |
| 11 | 1977 | 153 | |
| 12 | 1976 | 1 | |
| 13 | 1976 | 10 | |
| 14 | 1973 | 5 | |
| 15 | 1973 | 11 | |
| 16 | 1972 | 156 | |
| 17 | 1971 | 24 | |
| 18 | 1971 | 10 | |
| 19 | Study of dose-dependent metabolism of 5,5-diphenyl-hydantoin in the rat using new methodology for isolation and quantitation of metabolites in vivo and in vitro. | 1971 | 52 |
| 20 | 1968 | 21 |
About Robert E. Rangno
Robert E. Rangno is a scholar working on Anesthesiology and Pain Medicine, Developmental Biology and Analytical Chemistry, having authored 27 papers that have together received 1.2k indexed citations. Recurring topics across this work include Anesthesia and Sedative Agents (5 papers), Cardiac electrophysiology and arrhythmias (4 papers), Cardiovascular Syncope and Autonomic Disorders (3 papers), Lipoproteins and Cardiovascular Health (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Analytical Methods in Pharmaceuticals (3 papers) and Analytical Chemistry and Chromatography (2 papers). The work is most often cited by research in Pharmacology (227 citations), Analytical Chemistry (166 citations) and Anesthesiology and Pain Medicine (82 citations). Robert E. Rangno has collaborated with scholars based in Canada and United States. Frequent co-authors include David G. Shand, Richard I. Ogilvie, Daniel Sitar, Kenneth M. Piafsky, Stanley Nattel, Gwyn H. Evans, Gunther van Loon, Richard L. Pardy, J. C. Hogg and Brian J. Sweetman. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Pharmacology, Clinical Chemistry, The American Journal of Cardiology and Journal of Applied Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.